Navigating the Federal Regulations: A Look at the Release of CFR Title 21, Volume 5 (2024 Edition)
We are pleased to announce a significant update for those involved with or interested in the regulations governing the food and drug industry in the United States. GovInfo.gov, the official online repository for U.S. government publications, has officially published the Code of Federal Regulations (CFR) Title 21, Volume 5 (2024 Edition). This release, made public on August 20, 2025, at 3:40 PM, marks an important moment in ensuring access to the most current and comprehensive regulatory information.
The Code of Federal Regulations serves as the codification of the general and permanent rules published in the Federal Register by the executive departments and agencies of the Federal Government. Title 21 specifically pertains to the Food and Drugs, a critical area that impacts public health, industry standards, and consumer safety.
This newly released Volume 5 of Title 21 contains a substantial body of regulations. While the exact contents are extensive and best explored directly, this volume typically covers a range of vital topics within the purview of the Food and Drug Administration (FDA). These often include, but are not limited to, regulations related to:
- Food Safety and Labeling: This encompasses rules governing the manufacturing, processing, packaging, and labeling of various food products, ensuring they meet stringent safety and information disclosure requirements.
- Drug Manufacturing and Control: Detailed regulations concerning the development, testing, approval, manufacturing, and post-market surveillance of pharmaceutical drugs are usually found within these pages.
- Medical Devices: Standards and requirements for the design, production, and marketing of medical devices, from simple instruments to complex technologies, are also a key component.
- Biologics and Biotechnology: Regulations pertinent to biological products, including vaccines and blood products, as well as those related to advancements in biotechnology, are often addressed.
The availability of this updated volume is of paramount importance for a wide audience. This includes:
- Industry Professionals: Companies and individuals operating within the food, drug, and medical device sectors must adhere to these regulations. Access to the latest edition ensures compliance, facilitates product development, and supports responsible business practices.
- Legal and Compliance Experts: Lawyers, consultants, and compliance officers rely on the CFR for guidance in navigating the complex legal landscape of these industries.
- Researchers and Academics: Those studying public health, food science, pharmacology, and related fields benefit from having access to the foundational regulatory frameworks.
- Consumers and Advocacy Groups: Understanding these regulations can empower consumers and organizations dedicated to advocating for public health and safety.
GovInfo.gov’s commitment to providing timely and accessible government information is commendable. The efficient release of the CFR’s annual editions, such as this latest update to Title 21, Volume 5, is crucial for transparency and informed decision-making.
We encourage all stakeholders to visit GovInfo.gov to access and review CFR Title 21, Volume 5 (2024 Edition). This resource is an indispensable tool for anyone seeking to understand and comply with the federal regulations that shape our nation’s food and drug landscape.
AI has delivered the news.
The answer to the following question is obtained from Google Gemini.
govinfo.gov Code of FederalRegulations (Annual Edition) published ‘CFR-2024-title21-vol5’ at 2025-08-20 15:40. Please write a detailed article about this news in a polite tone with relevant information. Please reply in English with the article only.